Pharmacotherapy of Sexual Addiction - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Current Psychiatry Reports Année : 2020

Pharmacotherapy of Sexual Addiction

Résumé

Purpose of review: We reviewed recent data on sexual addiction and its treatment. We examined the different definitions of this disorder, related to the pathophysiological mechanisms. We addressed the pharmacological treatment of sexual addiction. Recent findings: Hypersexual behavior can be considered an addictive disorder. Sexual addiction is accompanied by significant psychiatric and addictive comorbidities and is responsible for life impairment. A comprehensive and efficient treatment must be proposed. Selective serotonin reuptake inhibitors seem the first-line pharmacological treatment for sexual addiction. Naltrexone could be another therapeutic option. Psychotherapy and preferentially cognitive-behavioral therapy should be used in association with pharmacotherapy and treatments of comorbidities.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-02881439 , version 1 (25-06-2020)

Identifiants

Citer

Leo Malandain, Jean-Victor Blanc, Florian Ferreri, Florence Thibaut. Pharmacotherapy of Sexual Addiction. Current Psychiatry Reports, 2020, 22 (6), pp.30. ⟨10.1007/s11920-020-01153-4⟩. ⟨inserm-02881439⟩
87 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More